Suppr超能文献

细胞外钙受体作为谷胱甘肽及其衍生物的靶点。

Extracellular Calcium Receptor as a Target for Glutathione and Its Derivatives.

机构信息

Department of Physiology, Wayne State University, Detroit, MI 48201, USA.

Van Andel Institute, Grand Rapids, MI 49503, USA.

出版信息

Int J Mol Sci. 2022 Jan 10;23(2):717. doi: 10.3390/ijms23020717.

Abstract

Extracellular glutathione (GSH) and oxidized glutathione (GSSG) can modulate the function of the extracellular calcium sensing receptor (CaSR). The CaSR has a binding pocket in the extracellular domain of CaSR large enough to bind either GSH or GSSG, as well as the naturally occurring oxidized derivative L-cysteine glutathione disulfide (CySSG) and the compound cysteinyl glutathione (CysGSH). Modeling the binding energies (ΔG) of CySSG and CysGSH to CaSR reveals that both cysteine derivatives may have greater affinities for CaSR than either GSH or GSSG. GSH, CySSG, and GSSG are found in circulation in mammals and, among the three, CySSG is more affected by HIV/AIDs and aging than either GSH or GSSG. The beta-carbon linkage of cysteine in CysGSH may model a new class of calcimimetics, exemplified by etelcalcetide. Circulating glutathionergic compounds, particularly CySSG, may mediate calcium-regulatory responses via receptor-binding to CaSR in a variety of organs, including parathyroids, kidneys, and bones. Receptor-mediated actions of glutathionergics may thus complement their roles in redox regulation and detoxification. The glutathionergic binding site(s) on CaSR are suggested to be a target for development of drugs that can be used in treating kidney and other diseases whose mechanisms involve CaSR dysregulation.

摘要

细胞外谷胱甘肽(GSH)和氧化型谷胱甘肽(GSSG)可以调节细胞外钙敏感受体(CaSR)的功能。CaSR 的细胞外结构域中有一个结合口袋,大小足以结合 GSH 或 GSSG,以及天然存在的氧化衍生物 L-半胱氨酸谷胱甘肽二硫化物(CySSG)和化合物半胱氨酰谷胱甘肽(CysGSH)。模拟 CySSG 和 CysGSH 与 CaSR 的结合能(ΔG)表明,这两种半胱氨酸衍生物与 CaSR 的亲和力可能大于 GSH 或 GSSG。GSH、CySSG 和 GSSG 存在于哺乳动物的循环中,在这三种物质中,CySSG 比 GSH 或 GSSG 更容易受到 HIV/AIDS 和衰老的影响。CysGSH 中半胱氨酸的β-碳键可能模拟了一类新的钙敏化剂,以依替膦酸二钠为例。循环中的谷胱甘肽化合物,特别是 CySSG,可能通过与 CaSR 的受体结合,在包括甲状旁腺、肾脏和骨骼在内的各种器官中介导钙调节反应。因此,谷胱甘肽的受体介导作用可能补充了它们在氧化还原调节和解毒中的作用。CaSR 上的谷胱甘肽结合位点被认为是开发药物的靶点,这些药物可用于治疗肾脏和其他疾病,其机制涉及 CaSR 失调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/118d/8776003/5f9848f6581b/ijms-23-00717-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验